Transdermal Delivery of Ondansetron Hydrochloride: Effects of Vehicles and Penetration Enhancers
The effects of vehicles and penetration enhancers on the in vitro permeation of ondansetron hydrochloride (OS) across dorsal hairless mouse skins were investigated. Various types of vehicles, including ester, alcohol, and ether and their mixtures were used, and then a series of fatty acids and fatty...
Gespeichert in:
Veröffentlicht in: | Drug development and industrial pharmacy 2004-01, Vol.30 (2), p.187-194 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 194 |
---|---|
container_issue | 2 |
container_start_page | 187 |
container_title | Drug development and industrial pharmacy |
container_volume | 30 |
creator | Gwak, Hye Sun Oh, Ik Sang Chun, In Koo |
description | The effects of vehicles and penetration enhancers on the in vitro permeation of ondansetron hydrochloride (OS) across dorsal hairless mouse skins were investigated. Various types of vehicles, including ester, alcohol, and ether and their mixtures were used, and then a series of fatty acids and fatty alcohols were employed as enhancers. Among pure vehicles used, water and ethanol showed high permeation fluxes, which were 48.2 ± 23.7 and 41.9 ± 17.9 µg cm2 per h, respectively. Even though propylene glycol monocaprylate (PGMC) alone did not show a high permeation rate, the skin permeability of OS was increased by the addition of diethylene glycol monoethyl ether (DGME); the highest flux was achieved at 40% of DGME. Also, the combination of PGMC and ethanol (80:20) or PGMC and propylene glycol (PG) (60:40) increased the permeation flux by six- and two-fold, respectively, compared to PGMC alone. The synergistic enhancement was also obtained by using PG-oleyl alcohol (OAl) cosolvent. The greatest flux was attained by the addition of unsaturated fatty acids at 3% concentration to PG. The enhancement factors with the addition of oleic acid or linoleic acid to PG were about 1250 and 450, respectively. But saturated fatty acids failed to show a significant enhancing effect. When the PGMC-DGME (60:40) cosolvent system was used as a vehicle, all fatty acids, including unsaturated fatty acids, failed to show significant enhancing effects. The results indicate that the combinations of oleic acid, linoleic acid, or oleyl alcohol with PG, or PGMC-DGME (60:40) cosolvent could be used for the design of the OS transdermal system. |
doi_str_mv | 10.1081/DDC-120028714 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmed_primary_15089053</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>17380141</sourcerecordid><originalsourceid>FETCH-LOGICAL-c447t-49160f7bc81486039c2161d37be95373b22fb44ffb3a42b7d804fa5c2b095ca3</originalsourceid><addsrcrecordid>eNqF0TtvFDEUBWALgcgmpKRF00A34OfYQ4d2lyRSpFCsaI3HvtZM5LWDPRu0_x5Hu-FRRKlc-DtXV-ci9JbgjwQr8mm1WraEYkyVJPwFWhBBcStkR1-iBWYda3vMxQk6LeUWY0J7IV6jEyKw6rFgC_Rjk00sDvLWhGYFYbqHvG-Sb26iqx8w5xSby73LyY4h5cnB52btPdi5PKjvME42QGlMdM03iNWbeaqRdRxNtJDLG_TKm1Dg_Pieoc3X9WZ52V7fXFwtv1y3lnM5t7wnHfZysIpw1WHWW0o64pgcoBdMsoFSP3Du_cAMp4N0CnNvhKUD7oU17Ax9OIy9y-nnDsqst1OxEIKJkHZFS6KYVF33LCSSKUw4qbA9QJtTKRm8vsvT1uS9Jlg_VK9r9fpP9dW_Ow7eDVtwf_Wx6wreH4Ep1gRfi7dT-cd1XHGCq1MHN0Wf6l1-pRycns2-9v8YYk_tIP-LjmDCPFqTQd-mXY71AE9s_xuwVK-1</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17380141</pqid></control><display><type>article</type><title>Transdermal Delivery of Ondansetron Hydrochloride: Effects of Vehicles and Penetration Enhancers</title><source>MEDLINE</source><source>Business Source Complete</source><source>Taylor & Francis Medical Library - CRKN</source><source>Taylor & Francis Journals Complete</source><creator>Gwak, Hye Sun ; Oh, Ik Sang ; Chun, In Koo</creator><creatorcontrib>Gwak, Hye Sun ; Oh, Ik Sang ; Chun, In Koo</creatorcontrib><description>The effects of vehicles and penetration enhancers on the in vitro permeation of ondansetron hydrochloride (OS) across dorsal hairless mouse skins were investigated. Various types of vehicles, including ester, alcohol, and ether and their mixtures were used, and then a series of fatty acids and fatty alcohols were employed as enhancers. Among pure vehicles used, water and ethanol showed high permeation fluxes, which were 48.2 ± 23.7 and 41.9 ± 17.9 µg cm2 per h, respectively. Even though propylene glycol monocaprylate (PGMC) alone did not show a high permeation rate, the skin permeability of OS was increased by the addition of diethylene glycol monoethyl ether (DGME); the highest flux was achieved at 40% of DGME. Also, the combination of PGMC and ethanol (80:20) or PGMC and propylene glycol (PG) (60:40) increased the permeation flux by six- and two-fold, respectively, compared to PGMC alone. The synergistic enhancement was also obtained by using PG-oleyl alcohol (OAl) cosolvent. The greatest flux was attained by the addition of unsaturated fatty acids at 3% concentration to PG. The enhancement factors with the addition of oleic acid or linoleic acid to PG were about 1250 and 450, respectively. But saturated fatty acids failed to show a significant enhancing effect. When the PGMC-DGME (60:40) cosolvent system was used as a vehicle, all fatty acids, including unsaturated fatty acids, failed to show significant enhancing effects. The results indicate that the combinations of oleic acid, linoleic acid, or oleyl alcohol with PG, or PGMC-DGME (60:40) cosolvent could be used for the design of the OS transdermal system.</description><identifier>ISSN: 0363-9045</identifier><identifier>EISSN: 1520-5762</identifier><identifier>DOI: 10.1081/DDC-120028714</identifier><identifier>PMID: 15089053</identifier><language>eng</language><publisher>Colchester: Informa UK Ltd</publisher><subject>Adjuvants, Pharmaceutic - chemistry ; Adjuvants, Pharmaceutic - pharmacology ; Administration, Cutaneous ; Animals ; Antiemetics - administration & dosage ; Antiemetics - chemistry ; Antiemetics - pharmacokinetics ; Biological and medical sciences ; Feasibility Studies ; General pharmacology ; In Vitro Techniques ; Male ; Medical sciences ; Mice ; Mice, Hairless ; Ondansetron - administration & dosage ; Ondansetron - chemistry ; Ondansetron - pharmacokinetics ; Ondansetron hydrochloride ; Penetration enhancers ; Permeability ; Pharmaceutical technology. Pharmaceutical industry ; Pharmaceutical Vehicles - chemistry ; Pharmaceutical Vehicles - pharmacology ; Pharmacology. Drug treatments ; Skin Absorption ; Transdermal delivery ; Vehicles</subject><ispartof>Drug development and industrial pharmacy, 2004-01, Vol.30 (2), p.187-194</ispartof><rights>2004 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted 2004</rights><rights>2004 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c447t-49160f7bc81486039c2161d37be95373b22fb44ffb3a42b7d804fa5c2b095ca3</citedby><cites>FETCH-LOGICAL-c447t-49160f7bc81486039c2161d37be95373b22fb44ffb3a42b7d804fa5c2b095ca3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.tandfonline.com/doi/pdf/10.1081/DDC-120028714$$EPDF$$P50$$Ginformahealthcare$$H</linktopdf><linktohtml>$$Uhttps://www.tandfonline.com/doi/full/10.1081/DDC-120028714$$EHTML$$P50$$Ginformahealthcare$$H</linktohtml><link.rule.ids>314,780,784,27924,27925,59647,59753,60436,60542,61221,61256,61402,61437</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=15648410$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15089053$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gwak, Hye Sun</creatorcontrib><creatorcontrib>Oh, Ik Sang</creatorcontrib><creatorcontrib>Chun, In Koo</creatorcontrib><title>Transdermal Delivery of Ondansetron Hydrochloride: Effects of Vehicles and Penetration Enhancers</title><title>Drug development and industrial pharmacy</title><addtitle>Drug Dev Ind Pharm</addtitle><description>The effects of vehicles and penetration enhancers on the in vitro permeation of ondansetron hydrochloride (OS) across dorsal hairless mouse skins were investigated. Various types of vehicles, including ester, alcohol, and ether and their mixtures were used, and then a series of fatty acids and fatty alcohols were employed as enhancers. Among pure vehicles used, water and ethanol showed high permeation fluxes, which were 48.2 ± 23.7 and 41.9 ± 17.9 µg cm2 per h, respectively. Even though propylene glycol monocaprylate (PGMC) alone did not show a high permeation rate, the skin permeability of OS was increased by the addition of diethylene glycol monoethyl ether (DGME); the highest flux was achieved at 40% of DGME. Also, the combination of PGMC and ethanol (80:20) or PGMC and propylene glycol (PG) (60:40) increased the permeation flux by six- and two-fold, respectively, compared to PGMC alone. The synergistic enhancement was also obtained by using PG-oleyl alcohol (OAl) cosolvent. The greatest flux was attained by the addition of unsaturated fatty acids at 3% concentration to PG. The enhancement factors with the addition of oleic acid or linoleic acid to PG were about 1250 and 450, respectively. But saturated fatty acids failed to show a significant enhancing effect. When the PGMC-DGME (60:40) cosolvent system was used as a vehicle, all fatty acids, including unsaturated fatty acids, failed to show significant enhancing effects. The results indicate that the combinations of oleic acid, linoleic acid, or oleyl alcohol with PG, or PGMC-DGME (60:40) cosolvent could be used for the design of the OS transdermal system.</description><subject>Adjuvants, Pharmaceutic - chemistry</subject><subject>Adjuvants, Pharmaceutic - pharmacology</subject><subject>Administration, Cutaneous</subject><subject>Animals</subject><subject>Antiemetics - administration & dosage</subject><subject>Antiemetics - chemistry</subject><subject>Antiemetics - pharmacokinetics</subject><subject>Biological and medical sciences</subject><subject>Feasibility Studies</subject><subject>General pharmacology</subject><subject>In Vitro Techniques</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Mice</subject><subject>Mice, Hairless</subject><subject>Ondansetron - administration & dosage</subject><subject>Ondansetron - chemistry</subject><subject>Ondansetron - pharmacokinetics</subject><subject>Ondansetron hydrochloride</subject><subject>Penetration enhancers</subject><subject>Permeability</subject><subject>Pharmaceutical technology. Pharmaceutical industry</subject><subject>Pharmaceutical Vehicles - chemistry</subject><subject>Pharmaceutical Vehicles - pharmacology</subject><subject>Pharmacology. Drug treatments</subject><subject>Skin Absorption</subject><subject>Transdermal delivery</subject><subject>Vehicles</subject><issn>0363-9045</issn><issn>1520-5762</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqF0TtvFDEUBWALgcgmpKRF00A34OfYQ4d2lyRSpFCsaI3HvtZM5LWDPRu0_x5Hu-FRRKlc-DtXV-ci9JbgjwQr8mm1WraEYkyVJPwFWhBBcStkR1-iBWYda3vMxQk6LeUWY0J7IV6jEyKw6rFgC_Rjk00sDvLWhGYFYbqHvG-Sb26iqx8w5xSby73LyY4h5cnB52btPdi5PKjvME42QGlMdM03iNWbeaqRdRxNtJDLG_TKm1Dg_Pieoc3X9WZ52V7fXFwtv1y3lnM5t7wnHfZysIpw1WHWW0o64pgcoBdMsoFSP3Du_cAMp4N0CnNvhKUD7oU17Ax9OIy9y-nnDsqst1OxEIKJkHZFS6KYVF33LCSSKUw4qbA9QJtTKRm8vsvT1uS9Jlg_VK9r9fpP9dW_Ow7eDVtwf_Wx6wreH4Ep1gRfi7dT-cd1XHGCq1MHN0Wf6l1-pRycns2-9v8YYk_tIP-LjmDCPFqTQd-mXY71AE9s_xuwVK-1</recordid><startdate>20040101</startdate><enddate>20040101</enddate><creator>Gwak, Hye Sun</creator><creator>Oh, Ik Sang</creator><creator>Chun, In Koo</creator><general>Informa UK Ltd</general><general>Taylor & Francis</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>20040101</creationdate><title>Transdermal Delivery of Ondansetron Hydrochloride: Effects of Vehicles and Penetration Enhancers</title><author>Gwak, Hye Sun ; Oh, Ik Sang ; Chun, In Koo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c447t-49160f7bc81486039c2161d37be95373b22fb44ffb3a42b7d804fa5c2b095ca3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Adjuvants, Pharmaceutic - chemistry</topic><topic>Adjuvants, Pharmaceutic - pharmacology</topic><topic>Administration, Cutaneous</topic><topic>Animals</topic><topic>Antiemetics - administration & dosage</topic><topic>Antiemetics - chemistry</topic><topic>Antiemetics - pharmacokinetics</topic><topic>Biological and medical sciences</topic><topic>Feasibility Studies</topic><topic>General pharmacology</topic><topic>In Vitro Techniques</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Mice</topic><topic>Mice, Hairless</topic><topic>Ondansetron - administration & dosage</topic><topic>Ondansetron - chemistry</topic><topic>Ondansetron - pharmacokinetics</topic><topic>Ondansetron hydrochloride</topic><topic>Penetration enhancers</topic><topic>Permeability</topic><topic>Pharmaceutical technology. Pharmaceutical industry</topic><topic>Pharmaceutical Vehicles - chemistry</topic><topic>Pharmaceutical Vehicles - pharmacology</topic><topic>Pharmacology. Drug treatments</topic><topic>Skin Absorption</topic><topic>Transdermal delivery</topic><topic>Vehicles</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gwak, Hye Sun</creatorcontrib><creatorcontrib>Oh, Ik Sang</creatorcontrib><creatorcontrib>Chun, In Koo</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Drug development and industrial pharmacy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gwak, Hye Sun</au><au>Oh, Ik Sang</au><au>Chun, In Koo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Transdermal Delivery of Ondansetron Hydrochloride: Effects of Vehicles and Penetration Enhancers</atitle><jtitle>Drug development and industrial pharmacy</jtitle><addtitle>Drug Dev Ind Pharm</addtitle><date>2004-01-01</date><risdate>2004</risdate><volume>30</volume><issue>2</issue><spage>187</spage><epage>194</epage><pages>187-194</pages><issn>0363-9045</issn><eissn>1520-5762</eissn><abstract>The effects of vehicles and penetration enhancers on the in vitro permeation of ondansetron hydrochloride (OS) across dorsal hairless mouse skins were investigated. Various types of vehicles, including ester, alcohol, and ether and their mixtures were used, and then a series of fatty acids and fatty alcohols were employed as enhancers. Among pure vehicles used, water and ethanol showed high permeation fluxes, which were 48.2 ± 23.7 and 41.9 ± 17.9 µg cm2 per h, respectively. Even though propylene glycol monocaprylate (PGMC) alone did not show a high permeation rate, the skin permeability of OS was increased by the addition of diethylene glycol monoethyl ether (DGME); the highest flux was achieved at 40% of DGME. Also, the combination of PGMC and ethanol (80:20) or PGMC and propylene glycol (PG) (60:40) increased the permeation flux by six- and two-fold, respectively, compared to PGMC alone. The synergistic enhancement was also obtained by using PG-oleyl alcohol (OAl) cosolvent. The greatest flux was attained by the addition of unsaturated fatty acids at 3% concentration to PG. The enhancement factors with the addition of oleic acid or linoleic acid to PG were about 1250 and 450, respectively. But saturated fatty acids failed to show a significant enhancing effect. When the PGMC-DGME (60:40) cosolvent system was used as a vehicle, all fatty acids, including unsaturated fatty acids, failed to show significant enhancing effects. The results indicate that the combinations of oleic acid, linoleic acid, or oleyl alcohol with PG, or PGMC-DGME (60:40) cosolvent could be used for the design of the OS transdermal system.</abstract><cop>Colchester</cop><pub>Informa UK Ltd</pub><pmid>15089053</pmid><doi>10.1081/DDC-120028714</doi><tpages>8</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0363-9045 |
ispartof | Drug development and industrial pharmacy, 2004-01, Vol.30 (2), p.187-194 |
issn | 0363-9045 1520-5762 |
language | eng |
recordid | cdi_pubmed_primary_15089053 |
source | MEDLINE; Business Source Complete; Taylor & Francis Medical Library - CRKN; Taylor & Francis Journals Complete |
subjects | Adjuvants, Pharmaceutic - chemistry Adjuvants, Pharmaceutic - pharmacology Administration, Cutaneous Animals Antiemetics - administration & dosage Antiemetics - chemistry Antiemetics - pharmacokinetics Biological and medical sciences Feasibility Studies General pharmacology In Vitro Techniques Male Medical sciences Mice Mice, Hairless Ondansetron - administration & dosage Ondansetron - chemistry Ondansetron - pharmacokinetics Ondansetron hydrochloride Penetration enhancers Permeability Pharmaceutical technology. Pharmaceutical industry Pharmaceutical Vehicles - chemistry Pharmaceutical Vehicles - pharmacology Pharmacology. Drug treatments Skin Absorption Transdermal delivery Vehicles |
title | Transdermal Delivery of Ondansetron Hydrochloride: Effects of Vehicles and Penetration Enhancers |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T19%3A23%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Transdermal%20Delivery%20of%20Ondansetron%20Hydrochloride:%20Effects%20of%20Vehicles%20and%20Penetration%20Enhancers&rft.jtitle=Drug%20development%20and%20industrial%20pharmacy&rft.au=Gwak,%20Hye%20Sun&rft.date=2004-01-01&rft.volume=30&rft.issue=2&rft.spage=187&rft.epage=194&rft.pages=187-194&rft.issn=0363-9045&rft.eissn=1520-5762&rft_id=info:doi/10.1081/DDC-120028714&rft_dat=%3Cproquest_pubme%3E17380141%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=17380141&rft_id=info:pmid/15089053&rfr_iscdi=true |